LENZ Therapeutics, Inc. (LENZ) Misses Q4 EPS by 46c

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q4 EPS of ($0.46).

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

You May Also Be Interested In

• Nvidia underperforms peers as report sparks rack delay worries
• Intercontinental Exchange (ICE) PT Lowered to $208 at Raymond James, 'we view the risk/reward as attractive'
• Diageo plc (DEO) call put ratio 1 call to 2.4 puts with a focus on July 80 puts as share price down 1.1%